| PPAR-alpha activation as a preconditioning-like intervention in rats in vivo confers myocardial protection against acute ischaemia-reperfusion injury: involvement of PI3K-Akt. | |
| | |
MedLine Citation:
|
PMID: 22809038 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Peroxisome proliferator-activated receptors (PPAR) regulate the expression of genes involved in lipid metabolism, energy production, and inflammation. Their role in ischaemia-reperfusion (I/R) is less clear, although research indicates involvement of PPARs in some forms of preconditioning. This study aimed to explore the effects of PPAR-α activation on the I/R injury and potential cardioprotective downstream mechanisms involved. Langendorff-perfused hearts of rats pretreated with the selective PPAR-α agonist WY-14643 (WY, pirinixic acid; 3 mg·(kg body mass)·day(-1); 5 days) were subjected to 30 min ischaemia - 2 h reperfusion with or without the phosphatidylinositol 3-kinase (PI3K)-Akt inhibitor wortmannin for the evaluation of functional (left ventricular developed pressure, LVDP) recovery, infarct size (IS), and reperfusion-induced arrhythmias. A 2-fold increase in baseline PPAR-α mRNA levels (qPCR) in the WY-treated group and higher post-I/R PPAR-α levels compared with those in untreated controls were accompanied by similar changes in the expression of PPAR-α target genes PDK4 and mCPT-1, regulating glucose and fatty acid metabolism, and by enhanced Akt phosphorylation. Post-ischaemic LVDP restoration in WY-treated hearts reached 60% ± 9% of the pre-ischaemic values compared with 24% ± 3% in the control hearts (P < 0.05), coupled with reduced IS and incidence of ventricular fibrillation that was blunted by wortmannin. Results indicate that PPAR-α up-regulation may confer preconditioning-like protection via metabolic effects. Downstream mechanisms of PPAR-α-mediated cardioprotection may involve PI3K-Akt activation. |
| | |
Authors:
|
Táňa Ravingerová; Slávka Carnická; Martina Nemčeková; Veronika Ledvényiová; Adriana Adameová; Tara Kelly; Eleftheria Barlaka; Eleftheria Galatou; Vinoth Kumar Megraj Khandelwal; Antigone Lazou |
Related Documents
:
|
22475348 - Early activation of myocardial matrix metalloproteinases and degradation of cardiac tro... 22273728 - Perflurooctanoic acid induces developmental cardiotoxicity in chicken embryos and hatch... 21563298 - Notch signaling in cardiac valve development and disease. 21984548 - Noninvasive reconstruction of the three-dimensional ventricular activation sequence dur... 9833138 - Force-frequency relation in patients with left ventricular hypertrophy and failure. 6605798 - Non-cardiac surgery in patients with prior myocardial revascularization. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-7-18 |
Journal Detail:
|
Title: Canadian journal of physiology and pharmacology Volume: - ISSN: 1205-7541 ISO Abbreviation: - Publication Date: 2012 Jul |
Date Detail:
|
Created Date: 2012-7-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372712 Medline TA: Can J Physiol Pharmacol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
a Institute for Heart Research, Slovak Academy of Sciences and Centre of Excellence of SAS NOREG, POB 104, Dubravská cesta 9, 840 05 Bratislava, Slovak Republic. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Antitumor Effects of Pinus massoniana Bark Extract in Murine Sarcoma S180 Both in Vitro and in Vivo.
Next Document: Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical c...